Ellsworth Advisors LLC Makes New Investment in Pacira BioSciences, Inc. $PCRX
MarketBeat
Ellsworth Advisors LLC purchased a new stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 44,284 shares of the company's stock, valued at approximately $1,109,000. Ellsworth Advisors
NASDAQ:PCRX